| Mrs Nisha Joseph Mattathil, PHARM D | |
|
39400 Paseo Padre Pkwy, Fremont, CA 94538-2310 | |
| (510) 248-7577 | |
| Not Available |
| Full Name | Mrs Nisha Joseph Mattathil |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 39400 Paseo Padre Pkwy, Fremont, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316034697 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 54758 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Nisha Joseph Mattathil, PHARM D 2119 Calle Vista Verde, Milpitas, CA 95035-7866 Ph: (408) 956-1553 | Mrs Nisha Joseph Mattathil, PHARM D 39400 Paseo Padre Pkwy, Fremont, CA 94538-2310 Ph: (510) 248-7577 |
News Archive
Researchers say 132 patients in the U.S. and Australia who were given the drug vemurafenib gained several extra months of life. The study published in the New England Journal of Medicine found that those on the drug lived an average of 16 months, compared with nine months on conventional treatment.
Genentech, Inc. a wholly owned member of the Roche Group, and Biogen Idec announced today a Phase III study (STAGE) of the investigational humanized anti-CD20 monoclonal antibody ocrelizumab given in combination with methotrexate (MTX) met its primary endpoint of improving signs and symptoms (as measured by American College of Rheumatology or ACR20 response) in rheumatoid arthritis (RA) patients who had an inadequate response to MTX at both 24 and 48 weeks.
BioMarin Pharmaceutical Inc. announced today that the Food and Drug Administration (FDA) has granted orphan drug designation for 3,4-diaminopyridine (3,4-DAP), amifampridine phosphate, for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has previously received orphan drug designation in the E.U.
Scientists from Graz, Austria, have now directly linked lipid metabolism and cancer-associated cachexia. Science reports via its online channel Science Express that mice deficient in the lipid degrading enzyme Adipose Triglyceride Lipase (ATGL) are fully protected against cancer-associated cachexia.
› Verified 4 days ago
Dr. Ranjit Singh Kali-rai, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 45372 Whitetail Ct, Fremont, CA 94539 Phone: 510-600-5125 | |
Heumin Li, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-248-7577 | |
Rahat Katyal, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 790 Saltillo Pl, Fremont, CA 94536 Phone: 510-796-0884 Fax: 510-562-5194 | |
Frances Tan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 779 Emerson Ct, Fremont, CA 94539 Phone: 408-966-9696 | |
Priti Chatwani, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 41766 Covington Dr, Fremont, CA 94539 Phone: 510-754-6479 | |
Kandie Ann Rago, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4020 Fremont Hub, Fremont, CA 94538 Phone: 510-791-9108 | |
Sejal Parikh, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3860 Decoto Rd, Fremont, CA 94555 Phone: 510-793-9798 |